Clinical Research Focus. 41st Edition EMA Backs New CAR-T Therapy for Adult Acute Lymphoblastic Leukemia The EMA has recommended conditional approval of Aucatzyl, a CAR T-cell therapy for adults 26+ with relapsed or refractory B-cell ALL. The treatment reprograms a patient’s own immune cells to target cancer and has shown strong remission results in trials. If approved by the European Read more
Top 10 ASCO 2025 insights for oncology clinical trial sponsors – Cromos Pharm
Post-ASCO 2025 Insights: What Oncology Sponsors Need To Know The 2025 ASCO Annual Meeting, held in Chicago, IL from May 30 to June 3, featured more than 6,000 abstracts. Below are 10 of the most strategic and actionable insights for oncology sponsors from this year’s event:  1. Meta-Analysis of Surrogate Endpoints vs OS/QOL A poster summary (Abstract 11015) examined ~800 phase III oncology trials Read more
Clinical Research Focus 40th edition | Cromos Pharma
Clinical Research Focus. 40th Edition FDA to Phase Out Animal Testing for Monoclonal Antibody Drugs The FDA announced plans to phase out animal testing requirements for monoclonal antibody therapies, encouraging the use of New Approach Methodologies (NAMs) like AI models and human cell lines. A pilot program will test these alternatives, aiming to improve drug safety, cut costs, and speed Read more
World Asthma Day 2025: A New Era in Respiratory Care | Cromos Pharma
World Asthma Day 2025: A New Era in Respiratory Care Today marks World Asthma Day — a global moment to reflect on the progress made in respiratory health, and to recommit to solving the challenges that remain. Asthma affects over 262 million people worldwide, claiming hundreds of thousands of lives every year. And yet, the way we respond to severe asthma flare-ups has barely evolved Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us